The MULTINUTRIENT Maize Project: Results of Human Feeding Trial
NCT ID: NCT02373943
Last Updated: 2016-03-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2015-09-30
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Biofortified Maize to Improve Maternal and Infant Vitamin A Status
NCT02804490
Efficacy of β-carotene Biofortified Maize in Reducing Vitamin A Deficiency Among Children
NCT01695148
Effect of Daily Consumption of Orange Maize on Breast Milk Retinol in Lactating Zambian Women
NCT01922713
Determination of Changes in Total Body Stores of Vitamin A in Response to Orange Maize Consumption by Zambian Children
NCT01814891
Guatemala Biofortified Maize Study
NCT06650397
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After a first screen that will address physical conditions and lifestyle 18 volunteers (9 men and 9 women) who meet the eligibility criteria will be included in the study once they have read and sign the informed consent. The postprandial plasma all-trans retinol response to each test meal will be used to establish the bioavailability of provitamin A from fortified maize. The test meals will be consumed in random order separated by 1 week. Blood samples will be collected over 8 h. All-trans retinol will be analyzed in plasma by high pressure liquid chromatography (HPLC) with coulometric array electrochemical detection.
Mean AUC for all-trans retinol in plasma after ingestion of the β-carotene-fortified maize porridge, the white maize porridge with the β-carotene reference dose, and the white maize porridge will be compared.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
β-carotene biofortified maize
Participants will ingest porridge bF: this will be the β-carotene fortified maize porridge where each 250 g will be made with 50 g of dry maize flour obtained from fortified corn seeds. The contents of β-carotene and other provitamin A carotenoids in this flour will be determined before preparing the porridges.
β-carotene biofortified maize
Determination of all-trans retinol AUC values after the ingestion of 200 g porridge made with 50 g of flour of β-carotene fortified maize
white maize supplemented with β-carotene
Participants will ingest porridge F: this will be also a β-carotene fortified maize porridge but in this case it will be made with 50 g of dry maize flour obtained from non fortified corn seeds and supplemented with a 500-1500 µg β-carotene reference dose. The exact dose of β-carotene that will be added to these porridges will be established according to the amount of β-carotene found in the flour used with porridges BF.
β-carotene supplemented maize
Determination of all-trans retinol AUC values after the ingestion of 200 g porridge made with 50 g of flour of β-carotene supplemented maize
white maize
Participants will ingest porridge N which will be the control porridge and will be made with 50 g of dry maize flour obtained from non fortified corn seeds.
Normal (non biofortified) maize without added β-carotene
Determination of all-trans retinol AUC values after the ingestion of 200 g porridge made with 50 g of flour of normal maize
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
β-carotene biofortified maize
Determination of all-trans retinol AUC values after the ingestion of 200 g porridge made with 50 g of flour of β-carotene fortified maize
β-carotene supplemented maize
Determination of all-trans retinol AUC values after the ingestion of 200 g porridge made with 50 g of flour of β-carotene supplemented maize
Normal (non biofortified) maize without added β-carotene
Determination of all-trans retinol AUC values after the ingestion of 200 g porridge made with 50 g of flour of normal maize
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Persons who had not taken vitamin A or β-carotene supplements within the past month
Exclusion Criteria
* Frequent consumption of alcoholic beverages (1 drink/d)
* Current or recent (previous 1 mo) use of dietary supplements
* Current or recent (previous 6 mo) use of hormonal contraceptives
* Current or recent (previous 1 mo) use of medications known to affect lipid metabolism.
* History of restrictive eating
* BMI under 20 or over 30
* Lactose intolerance
* Vegetarians.
* Severe or symptomatic cardiac disease or hypertension
* History of bleeding disorders
* Chronic history of gastric, intestinal, liver, pancreatic, or renal disease
* Any portion of the stomach or the intestine removed (other than an appendectomy)
* History of intestinal obstruction, malabsorption, or use of antacid drugs; cancer (active or use of medications for a history of cancer treatment within the past 5 y)
* History of chronic alcoholism
* History of convulsive disorder
* Evidence of active drug abuse
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitat de Lleida
OTHER
Institut de Recerca Biomèdica de Lleida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Joan Antoni Schoenenberger
Dr. Joan Antoni Schoenenberger Arnaiz
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juan A Schoenenberger, Pharm D
Role: PRINCIPAL_INVESTIGATOR
Institut de Recerca Biomèdica de Lleida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitari Arnau de Vilanova
Lleida, LLeida, Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Li S, Nugroho A, Rocheford T, White WS. Vitamin A equivalence of the ss-carotene in ss-carotene-biofortified maize porridge consumed by women. Am J Clin Nutr. 2010 Nov;92(5):1105-12. doi: 10.3945/ajcn.2010.29802. Epub 2010 Sep 1.
Grune T, Lietz G, Palou A, Ross AC, Stahl W, Tang G, Thurnham D, Yin SA, Biesalski HK. Beta-carotene is an important vitamin A source for humans. J Nutr. 2010 Dec;140(12):2268S-2285S. doi: 10.3945/jn.109.119024. Epub 2010 Oct 27.
Christou P, Twyman RM. The potential of genetically enhanced plants to address food insecurity. Nutr Res Rev. 2004 Jun;17(1):23-42. doi: 10.1079/NRR200373.
Paine JA, Shipton CA, Chaggar S, Howells RM, Kennedy MJ, Vernon G, Wright SY, Hinchliffe E, Adams JL, Silverstone AL, Drake R. Improving the nutritional value of Golden Rice through increased pro-vitamin A content. Nat Biotechnol. 2005 Apr;23(4):482-7. doi: 10.1038/nbt1082. Epub 2005 Mar 27.
Gannon B, Kaliwile C, Arscott SA, Schmaelzle S, Chileshe J, Kalungwana N, Mosonda M, Pixley K, Masi C, Tanumihardjo SA. Biofortified orange maize is as efficacious as a vitamin A supplement in Zambian children even in the presence of high liver reserves of vitamin A: a community-based, randomized placebo-controlled trial. Am J Clin Nutr. 2014 Dec;100(6):1541-50. doi: 10.3945/ajcn.114.087379. Epub 2014 Oct 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ERCEA - PoC2013 - 619161
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.